{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:39:35Z","timestamp":1786653575559,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0301-4738.162612","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T07:13:36Z","timestamp":1439277216000},"page":"539","source":"Crossref","is-referenced-by-count":6,"title":["Mirtazapine-induced acute angle closure"],"prefix":"10.4103","volume":"63","author":[{"given":"Onur","family":"Durmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MehmetMurat","family":"Durna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.162612-1","first-page":"139","article-title":"Medication-induced acute angle closure attack","author":"Lai","year":"2012","journal-title":"Hong Kong Med J"},{"key":"key-10.4103\/0301-4738.162612-2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2415-5-23","article-title":"Citalopram associated with acute angle-closure glaucoma: Case report","author":"Croos","year":"2005","journal-title":"BMC Ophthalmol"},{"key":"key-10.4103\/0301-4738.162612-3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/eye.2011.128","article-title":"Non-steroidal drug-induced glaucoma","author":"Razeghinejad","year":"2011","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.162612-4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pharmthera.2012.08.013","article-title":"Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: Evidence from the bench and the bedside","author":"Graves","year":"2012","journal-title":"Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.162612-5","first-page":"121","article-title":"Mirtazapine in combination","author":"\u00c1lvarez","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"key":"key-10.4103\/0301-4738.162612-6","doi-asserted-by":"crossref","unstructured":"Alam A, Voronovich Z, Carley JA. A review of therapeutic uses of mirtazapine in psychiatric and medical conditions. Prim Care Companion CNS Disord 2013;15:PCC.13r01525.","DOI":"10.4088\/PCC.13r01525"},{"key":"key-10.4103\/0301-4738.162612-7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bjo.82.8.976a","article-title":"Acute glaucoma, chronic glaucoma, and serotoninergic drugs","author":"Eke","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.162612-8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/bjo.81.3.252","article-title":"Bilateral acute angle closure glaucoma after administration of paroxetine","author":"Kirwan","year":"1997","journal-title":"Br J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:31Z","timestamp":1786649971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.162612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"alternative-id":["162612"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.162612","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}